tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Alpha Teknova resumed with an Overweight at Stephens

Stephens resumed coverage of Alpha Teknova (TKNO) with an Overweight rating and $8 price target The company will benefit from growth in the biologics end market, the analyst tells investors in a research note. The firm believes Alpha continues to add to its clinical solutions customer base, which should drive revenue growth as demand ramps.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1